About Protein LSM14 homolog B
Protein LSM14 homolog B (LSM14B) is a protein
from Homo sapiens identified by UniProt accession
Q9BX40, 385 residues long.
MolForge cross-references it against 0 known binders and
44 disease associations.
Target properties
| Protein name | Protein LSM14 homolog B |
| UniProt accession | Q9BX40 |
| Gene | LSM14B |
| Organism | Homo sapiens |
| Length | 385 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (44)
Diseases linked to this target (Open Targets).
- alkaline phosphatase measurement · score 0.13
- Female infertility due to fertilization defect · score 0.07
- female infertility due to oocyte meiotic arrest · score 0.07
- mean reticulocyte volume · score 0.06
- oocyte maturation defect 9 · score 0.06
- Hydatidiform Mole · score 0.05
- hereditary persistence of fetal hemoglobin-sickle cell disease syndrome · score 0.05
- hemoglobin D disease · score 0.05
- primary ovarian insufficiency · score 0.05
- premature ovarian failure 19 · score 0.05
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q9BX40-F1 | alphafold | PREDICTED | 62.07 | — |
Amino-acid sequence (385 residues)
MSGSSGTPYL GSKISLISKA QIRYEGILYT IDTDNSTVAL AKVRSFGTED RPTDRPAPPR EEIYEYIIFR GSDIKDITVC EPPKAQHTLP QDPAIVQSSL GSASASPFQP HVPYSPFRGM APYGPLAASS LLSQQYAASL GLGAGFPSIP VGKSPMVEQA VQTGSADNLN AKKLLPGKGT TGTQLNGRQA QPSSKTASDV VQPAAVQAQG QVNDENRRPQ RRRSGNRRTR NRSRGQNRPT NVKENTIKFE GDFDFESANA QFNREELDKE FKKKLNFKDD KAEKGEEKDL AVVTQSAEAP AEEDLLGPNC YYDKSKSFFD NISSELKTSS RRTTWAEERK LNTETFGVSG RFLRGRSSRG GFRGGRGNGT TRRNPTSHRA GTGRV
Explore Protein LSM14 homolog B with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets